Distribution of Dendritic Cells in Normal Human Salivary Glands by Le, An et al.
Acta Histochem. Cytochem. 44 (4): 165–173, 2011
doi:10.1267/ahc.11010
© 2011 The Japan Society of Histochemistry and Cytochemistry
Advance Publication
AHC Acta Histochemica et Cytochemica 0044-5991 1347-5800 Japan Society of Histochemistry and Cytochemistry Tokyo, Japan AHC11010 10.1267/ahc.11010 Regular Article
Distribution of Dendritic Cells in Normal Human Salivary Glands
An Le1,*, Michele Saverin1,* and Arthur R. Hand1
1Division of Pediatric Dentistry, Department of Craniofacial Sciences, University of Connecticut School of Dental Medicine, 
Farmington, CT 06030, USA
Correspondence to: Arthur R. Hand, Department of Craniofacial
Sciences, University of Connecticut Health Center, 263 Farmington
Ave., MC1610, Farmington, CT 06030 USA. 
E-mail: hand@nso1.uchc.edu
*These authors contributed equally to this work.
00 Received March 3, 2011; accepted June 13, 2011; published online July 20, 2011
© 2011 The Japan Society of Histochemistry and Dendritic cells (DC) are believed to contribute to development of autoimmune sialadenitis,
but little is known about their distribution in normal salivary glands. In this study, DC were
identified and their distribution was determined in normal human parotid and submandibular
glands. For light microscopy, salivary gland sections were stained with H&E or immuno-
cytochemically using antibodies to DC markers. Transmission electron microscopy (TEM)
was used to evaluate the ultrastructural characteristics of DC. In H&E sections, elongated,
irregularly shaped nuclei were occasionally seen in the striated and excretory duct epithelium.
Immunolabeling with anti-HLA-DR, anti-CD11c and anti-S100 revealed DC with numerous
processes extending between ductal epithelial cells, often close to the lumen. Morphometric
analyses indicated that HLA-DR-positive DC occupied approximately 4–11% of the duct wall
volume. Similar reactive cells were present in acini, intercalated ducts and interstitial tissues.
TEM observations revealed cells with indented nuclei containing dense chromatin, pale
cytoplasm with few organelles, and lacking junctional attachments to adjacent cells. These
results indicate that DC are abundant constituents of normal human salivary glands. Their
location within ductal and acinar epithelium suggests a role in responding to foreign antigens
and/or maintaining immunological tolerance to salivary proteins.
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I. Introduction
Dendritic cells (DC) are antigen presenting cells (APC)
that play a major role in the control of immune responses.
DC affect immune responses via secretion of cytokines and
exposure of naïve B- and T-lymphocytes to antigens. They
process and display foreign antigens on their cell surface
with the major histocompatibility complexes I and II (MHC
I and MHC II). Antigen exposure along with stimulation by
various cytokines and other factors induces immature DC
to undergo phenotypic and functional changes from efficient
antigen-capturing cells to APC, and triggers their migration
to secondary lymphoid organs, where they recruit and
stimulate T-cells by releasing cytokines and chemokines
such as interleukin (IL)-12, IL-8, and macrophage inflam-
matory protein (MIP)-1α and β, and by upregulating a
variety of accessory and costimulatory molecules. Dendritic
cells also play an important role in the induction of T-cell
tolerance to self-antigens. Central tolerance occurs in the
thymus by deletion of developing T-cells. Peripheral
tolerance occurs in lymphoid organs by the induction of
anergy or deletion of mature T-cells [3, 4, 10, 47].
The function of the salivary glands in the mucosal
immune system is well established, especially their role in
the secretion of immunoglobulins produced by local plasma
cells [6, 31]. In addition to immunoglobulin producing
plasma cells, macrophages, DC and T-cells are present in
the salivary glands of rodents and humans [8, 18, 24, 38,
44, 51]. In rat salivary glands, macrophages and DC are
present in the interstitial tissues [8, 44] and within the
epithelium of the intra- and interlobular ducts [44].
Macrophages isolated from rat salivary glands are able toLe et al. 166
efficiently present antigens to naïve CD4+ T-lymphocytes
[37]. Organized lymphoid tissue is present around the ducts
of minor salivary glands [32] and the main excretory duct
of monkey parotid gland [26]. In the latter study, lympho-
cytes and DC were the predominant intraepithelial immune
cells, located in close proximity to other DC, intraepithelial
lymphocytes and epithelial cells. DC previously have been
shown to be present in the interstitial connective tissue of
normal human major [51] and minor [18] salivary glands.
The possible role of APC and T-cells in the develop-
ment of Sjögren’s syndrome (SS) has generated considerable
interest [57]. Previous studies have shown that DC infiltrate
the submandibular gland of nonobese diabetic mice, a model
of SS, before lymphocytic infiltration and may play a role
in the initiation of SS [55]. Dendritic cells also have been
demonstrated in salivary glands of humans with SS and
other autoimmune diseases [16, 25, 27, 35, 36, 56, 58, 59],
and both DC and macrophages have been implicated in the
pathogenesis of SS [25, 36, 56, 58, 59].
The objectives of this study were to determine the
distribution of DC in normal human major salivary glands
using immunohistochemistry, and to characterize the mor-
phology of DC in the glands by transmission electron
microscopy (TEM). We show that DC are abundant
constituents of normal glands, and are present within the
epithelium of ducts and acini, in addition to the interstitial
connective tissue.
II. Materials and Methods
Tissue samples
Normal human salivary gland tissues were obtained
from 17 consenting patients undergoing surgery in the
Otorhinolaryngology Clinic at the University of Cagliari,
Italy. All procedures were approved by the Human Exper-
imentation Committee at the University of Cagliari, and the
use of the tissues at the University of Connecticut Health
Center was approved by the Institutional Review Board. The
samples were fixed in the operating suite and subsequently
shipped by express carrier to Connecticut for further
processing. In some cases processing and embedding for
TEM was completed in Cagliari before shipping.
Light microscopy and immunohistochemistry
Small pieces of glandular tissue were fixed in 4%
paraformaldehyde in 0.1 M sodium cacodylate buffer, pH
7.2, and stored in 1% buffered paraformaldehyde. The
tissues were processed for paraffin embedding by standard
methods and 5 μm sections were cut and stained with
hematoxylin and eosin (H&E). Immunohistochemistry was
performed manually using sections collected on Superfrost/
Plus slides (Fisher Scientific, Pittsburgh, PA). Antigen
retrieval with 5% urea/50 mM β-mercaptoethanol or 10 mM
citrate buffer, pH 6.0, containing 0.05% Tween 20, at
95° was performed following paraffin removal. The sections
were treated with 0.3% H2O2 in 85% methanol, and non-
specific binding was blocked with 1% bovine serum albumin
(BSA)/5% normal goat serum (NGS) in phosphate buffered
saline (PBS). Sections were incubated with the following
primary antibodies: mouse monoclonal anti-human HLA-
DR, specific for the MHC II α-chain (DakoCytomation,
Carpinteria, CA, USA); rabbit polyclonal anti-human CD74,
which recognizes the MHC II invariant chain (Sigma
Prestige Antibodies, St. Louis, MO, USA); rabbit mono-
clonal anti-human CD11c, a marker for cells of the myeloid
lineage (Epitomics, Burlingame, CA, USA); CD123, a
marker for plasmacytoid dendritic cells (R&D Systems,
Minneapolis, MN); and rabbit polyclonal anti-bovine brain
S100, a calcium binding protein found in DC and other cells
(Serotec, Raleigh, NC, USA). The bound primary antibodies
were detected with a biotin-labeled secondary antibody, and
visualized using the VectaStain avidin-biotin-complex
(ABC) reagent (Vector Laboratories, Burlingame, CA, USA)
and peroxidase substrate solution (either diaminobenzidine-
H2O2 or Vector NovaRed substrate [Vector Laboratories]).
The sections were counterstained with hematoxylin, dehy-
drated, and coverslips were mounted with DPX (Electron
Microscopy Sciences, Hatfield, PA, USA). Immuno-
cytochemical controls included omission of the primary
antibody or substitution of the primary antibody with non-
immune IgG or an irrelevant antibody.
The sections were photographed in a Leitz Orthoplan
brightfield microscope using a Nikon Coolpix 5000 digital
camera. Images were transferred to a Macintosh Power PC
G4 computer, and background highlight levels and contrast
were adjusted in Adobe Photoshop (versions 6.0.1 or 7.0.1;
Adobe Systems Inc., San Jose, CA, USA).
The volume percentage of DC in the epithelium of the
striated and excretory ducts was determined by a point
counting method. Images of ducts in sections of 3 different
submandibular and 2 different parotid glands immunostained
with anti-HLA-DR antibody were opened in Photoshop and
a grid pattern was superimposed on the image. The number
of grid intersections lying over HLA-DR-positive DC
divided by the total number of intersections lying over the
duct wall, multiplied by 100, equaled the volume percentage
of the duct wall occupied by DC.
Transmission electron microscopy (TEM)
Morphological characteristics of DC were evaluated in
thin sections of plastic embedded human salivary gland
samples examined by TEM. Two different submandibular
gland samples and 2 parotid gland samples were utilized.
The tissues were fixed in 1.25% glutaraldehyde/1.0%
paraformaldehyde in 0.1 M sodium cacodylate buffer, pH
7.2, postfixed in 2% osmium tetroxide, treated with 0.25%
aqueous uranyl acetate, dehydrated in acetone and embedded
in Epon resin. Thin sections were cut with a diamond knife,
stained with uranyl acetate and lead citrate, and examined
and photographed in a JEOL 100CX or Philips CM10 TEM.
The developed negatives were scanned with an Epson
Perfection V750 Pro scanner, and levels and contrast were
adjusted in Photoshop.Dendritic Cells in Human Salivary Glands 167
III. Results
Light microscopy
Light microscopic examination of striated and excretory
ducts in H&E stained sections of parotid and submandibular
glands revealed the presence of occasional elongated or
irregularly shaped nuclei within the simple columnar or
pseudostratified epithelial lining of the duct wall (Fig. 1).
These nuclei typically were located basal to the nuclei of
the columnar epithelial cells, but above the basal surface of
the duct, and often extended horizontally along the duct
wall. Distinct cell borders were not visible and the cytoplasm
of these cells was not discernable from that of the
surrounding epithelial cells. Myoepithelial cells also may
be present in striated and excretory ducts of human salivary
glands [7, 11]; their nuclei typically were located along the
basal surfaces of the ducts (Fig. 1).
Immunohistochemistry
Dendritic cells express high levels of MHC II [3],
therefore immunohistochemistry with anti-HLA-DR anti-
body was used to identify DC in the salivary gland sections.
Numerous reactive cells with a dendritic morphology were
seen in the ducts, acini and interstitial tissues of the parotid
and submandibular glands (Fig. 2A–C; Fig. 3A–C). In
sections incubated with the anti-CD11c antibody (Fig. 3D),
a marker of cells derived from the myeloid lineage, reactive
cells were distributed similarly, although in general, fewer
cells were labeled. Like the HLA-DR-positive cells, many
of the CD11c-positive cells had a dendritic morphology. In
several instances, incubation of one section with anti-HLA-
DR and the adjacent section with anti-CD11c revealed
labeling of the same cell with both antibodies (Fig. 3E and
F; Fig. 3G–I). In the striated and excretory ducts, the
processes of the DC were located in between the epithelial
cells, occasionally extending more than 20 μm along the
duct wall (Fig. 2A and B). The DC processes often were
located basally in the duct epithelium, but processes also
could be found apical to the duct cell nuclei (Fig. 2A and
C; Fig. 3A–C), sometimes close to the luminal surface.
Occasionally, multiple processes extended toward the lumen,
creating a “pitchfork” appearance (inset, Fig. 2A and B).
Dendritic cells also were present in intercalated ducts, but
these were observed less frequently. In the acini, DC were
located in the intercellular spaces between adjacent acinar
cells (Fig. 2A and B). The size, shape, location and reactivity
of these cells clearly distinguished them from the acinar and
myoepithelial cells. Dendritic cells also were distributed
throughout the interstitial tissues (Fig. 2A and B; Fig. 3B,
D and F).
Occasionally, some acinar and duct epithelial cells
showed reactivity with the anti-HLA-DR and anti-CD11c
antibodies, and blood vessel endothelium was frequently
labeled by the anti-HLA-DR antibody (Fig. 2A and B;
Fig. 3F).
The distribution of DC in the submandibular and parotid
glands was similar, although intraepithelial DC were more
frequent in the submandibular gland. The volume percentage
of cells labeled with the anti-HLA-DR antibody in striated
and excretory ducts was determined using a point counting
method. In the submandibular gland, HLA-DR-positive DC
constituted 10.6±1.9% of the volume of the duct wall. In
the parotid gland, the proportion of the duct wall occupied
by DC was 4.5±0.9%.
Anti-S100 reactivity was present in cells with a
dendritic morphology in the striated duct epithelium
(Fig. 3J–L). Only a few S100-reactive cells were observed
in the excretory ducts. As noted by other investigators,
peripheral nerves and serous acinar cells also labeled with
the anti-S100 antibody [12, 17, 33]. In sections incubated
with the anti-CD74 (MHC II invariant chain) antibody,
fewer reactive DC were observed, and duct epithelial cells
frequently were labeled (Fig. 3M). Labeled DC were present
in the duct epithelium (Fig. 3M) and in the acini (Fig. 3N),
as well as scattered throughout the interstitial tissues
(Fig. 3N). Occasional small inflammatory foci, consisting
mainly of lymphocytes, were seen near small ducts in some
Fig. 1. Light microscopy of human major salivary gland striated
ducts (SD) stained with H&E. Bars=20 μm. A, parotid gland. B,
submandibular gland. Arrows indicate nuclei of probable DC
within the duct epithelium. Arrowheads indicate nuclei of possible
myoepithelial cells at the basal surface of the duct. AC, acini.Le et al. 168
of the otherwise normal glands. These foci also contained
cells labeled with anti-CD74, as well as with anti-HLA-DR
and anti-CD11c (data not shown).
Antibody to CD123, a marker of plasmacytoid DC,
was used in an attempt to further characterize the reactivity
of the salivary gland DC. Plasmacytoid DC recognize nucleic
acids and produce large amounts of type I interferon in
response to viral infections [9]. No reactive DC were seen
in sections of normal glands incubated with antibody to
CD123. A few labeled cells were observed in a degenerating
area of one gland, suggesting that plamacytoid DC may have
entered the gland in response to autoimmune sialadenitis
(data not shown).
In control sections, no labeling was seen when the
primary antibody was omitted from the labeling sequence,
or when non-immune IgG or an irrelevant antibody was
substituted for the primary antibody (Fig. 2D).
Electron microscopy
Examination of thin sections of the parotid and
submandibular glands revealed the presence of small cells
with the characteristics of DC within the epithelium of the
ducts and acini (Figs. 4 and 5). The nucleus typically was
indented and had dense peripheral heterochromatin. The
cytoplasm contained relatively few organelles, i.e. mitochon-
dria, short cisternae of endoplasmic reticulum, a few dense
bodies, and cytoskeletal filaments. Birbeck granules, char-
acteristic of Langerhans cells [5], were not seen in the
salivary gland DC. No intercellular junctions, such as tight
junctions, desmosomes or gap junctions, were observed
between the DC and adjacent epithelial cells. The inter-
cellular space surrounding the cell bodies of DC often
appeared somewhat widened, possibly due to the lack of
intercellular junctions and subsequent shrinkage of the cell
during fixation and processing. Occasionally, apparent proc-
Fig. 2. Light microscopic immunohistochemistry with anti-HLA-DR. Bars=20 μm; 10 μm (inset). A and B and inset, submandibular gland; C,
parotid gland. Black arrowheads indicate examples of labeled DC in the epithelium of striated (SD) and excretory (ED) ducts. Open arrowheads
indicate labeled DC processes near the luminal surface of the ducts. Black arrows indicate DC within acini (AC). Basally located DC often
extend multiple processes toward the lumen (inset, panels A and B). Numerous labeled DC are present in the interstitial tissue (small crossed
arrows); around the acini it often is difficult to tell if these cells are located in the interstitium or within the acini. Note reactivity of blood vessel
(BV) endothelium. D, submandibular gland, non-immune IgG control.Dendritic Cells in Human Salivary Glands 169
esses of the DC were seen extending away from the cell
body, often along the base of the duct or acinus (Fig. 5).
IV. Discussion
The results of this study indicate that cells with the
morphology and immunohistochemical characteristics of
dendritic cells are present in substantial numbers within the
epithelium and interstitial tissues of normal human salivary
glands. Although previous light microscopic studies have
shown that DC are present in the interstitium of normal
human glands [18, 51], their presence within the epithelium
of the ducts and acini has not been described previously.
The DC were consistently labeled with antibody to HLA-
DR, indicating the expression of MHC II, a characteristic,
although not specific, marker of DC. Both intraepithelial
and interstitial DC were labeled. The DC also labeled with
antibody to CD11c, a marker of the myeloid lineage that
differentiates myeloid or classical DC from plasmacytoid
DC [9, 22, 30, 41]. As tissue macrophages also may express
Fig. 3. Light microscopic immunohistochemistry. Bars=20 μm. A and C, parotid gland, B, submandibular gland; anti-HLA-DR. Labeled
processes (open arrowheads) of DC extend toward the lumen of the ducts. A basally located DC (black arrowhead) also is seen in panel A,
and interstitial DC are seen in panel B (small crossed arrow). D, submandibular gland, anti-CD11c. Several labeled DC are present within the
epithelium of a striated duct. A few labeled DC are present in the interstitium (small crossed arrow). E and F, submandibular gland. A striated
duct is seen in adjacent sections incubated with anti-CD11c (E) and anti-HLA-DR (F). The same cell (right arrowheads) and process (left
arrowheads) are positive for both CD11c and HLA-DR. The small arrows in F indicate HLA-DR-positive endothelium of a small blood vessel.
The small crossed arrow indicates a labeled DC in the interstitium. G, H, and I, submandibular gland. A small striated duct is seen in three
adjacent sections incubated with anti-HLA-DR (G), anti-CD11c (H) and anti-HLA-DR (I). The same cells (arrowheads) show reactivity
for both HLA-DR and CD11c. J, K and L, submandibular gland, anti-S100. Reactive cells, some with long processes, are present in the
epithelium of striated ducts. Nerve bundles in the interstitital tissue show reactivity, and acinar cells also are labeled. M and N, submandibular
gland, anti-CD74. A few reactive DC are present in the ducts (black arrowheads) and acini (arrows). Some duct epithelial cells (open
arrowheads) are labeled. The small crossed arrow indicates a labeled DC in the interstitium.Le et al. 170
CD11c, some of the labeled cells may be macrophages rather
than DC. However, many of the CD11c-positive cells
exhibited a dendritic morphology, and by examination of
serial sections were shown to also be HLA-DR-positive.
Antibody to CD74 labeled intraepithelial and interstitial
cells, but fewer labeled cells were observed than with anti-
HLA-DR or anti-CD11c. Cells with a dendritic morphology
located in the ductal epithelium also labeled with anti-S100.
Abundant labeling for S100 was observed in the interstitium,
however most of this appeared to be due to the reactivity
of nerve fibers [12]. Although these markers are not specific
for DC, and may be expressed by macrophages [14] and
other cell types, their expression by cells with typical
dendritic morphology strongly suggests that the observed
cells are in fact DC.
The presence of interstitial DC in normal rodent [8, 24,
44, 46] salivary glands has been demonstrated previously.
We also showed that DC are present within the epithelium
of ducts in rat salivary glands [44]. The present results
indicate that intraepithelial DC are commonly found in the
acini and ducts of normal human major salivary glands.
Morphometric analyses indicate that DC may constitute as
much as 10% of the cellular volume of the wall of the
striated and excretory ducts. This large number of cells
suggests that salivary gland DC play a significant role in
the normal function of these organs.
Epithelial cells of the glands occasionally exhibited
reactivity with the antibodies used in this study. With the
anti-HLA-DR and anti-CD11c antibodies, occasional acinar
cells were labeled, and a very faint labeling of a few duct
cells was seen. Labeling of salivary gland duct cells with
antibodies detecting MHC II epitopes has been reported in
normal rodent salivary glands [29, 46], and in animal models
of SS [43]. More extensive salivary epithelial expression of
Fig. 4. Electron micrographs of submandibular gland striated duct. Bars=1 μm. A, probable DC (arrow) located in the basal region of the duct
epithelium (SD). B, higher magnification of cell in panel A showing fewer organelles and mitochondria than adjacent epithelial cells, and
absence of intercellular junctions. The cell marked with an asterisk is either a myoepithelial cell or the extended process of a basal duct cell. BV,
blood vessel.
Fig. 5. Electron micrographs of acini. Bars=1 mm. A, submandib-
ular gland. A probable DC (arrow) with an elongated nucleus and a
long process (arrowheads), and a macrophage-like cell (Mac) are
enclosed by a myoepithelial cell process (MEC) at the base of the
acinus. ID, intercalated duct. B, parotid gland. A probable DC
(arrow) with a dense, indented nucleus, few organelles and a por-
tion of its process (arrowhead), is surrounded by acinar cells (AC).Dendritic Cells in Human Salivary Glands 171
MHC II antigens may be induced in various experimental
conditions, such as interferon-γ treatment [46] and in
estrogen-deficient mice [1]. Epithelial MHC II expression
has been described in normal human salivary glands [20,
51, 52] and is increased in glands of SS patients [2, 13, 15,
18, 49, 50, 52] and patients with various connective tissue
diseases [28]. It is assumed that MHC II-positive epithelial
cells are capable of presenting antigens to T-cells, but it
remains uncertain whether the increased epithelial expres-
sion of MHC II precedes or is a consequence of autoimmune
disease.
We also observed HLA-DR labeling of the endothelium
of small blood vessels. Previous studies have demonstrated
endothelial expression of MHC II in normal salivary glands
[51], and in glands of SS patients [2, 18]. Endothelial cell
MHC II expression is upregulated by interferon-γ [39, 46],
and is increased in several autoimmune diseases [53].
The ultrastructure of DC in human salivary glands is
similar to that described for DC in other tissues, such as the
rat kidney [19], incisor enamel organ [48], salivary glands
[44] and human bronchi [42]. The nuclei usually are oval
or elongated in shape, often with one or more indentations.
Their cytoplasm contains fewer organelles than acinar or
duct cells, but occasionally includes dense lysosome-like
bodies and small phagocytic vacuoles. Unlike Langerhans
cells found in skin, oral and vaginal mucosa, salivary gland
DC lack Birbeck granules, which have been shown to be
part of the endosomal system [54].
Salivary gland DC apparently lack intercellular junc-
tions such as tight junctions and desmosomes, typical of
most epithelial tissues. They also lack gap junctions,
commonly found between salivary gland acinar cells and
between intercalated duct cells. The absence of intercellular
junctions most likely accounts for the widened intercellular
spaces between the DC and the adjacent epithelial cells. In
contrast, DC present in the intestinal epithelium have been
shown to extend processes to the luminal surface, where
they express tight junction proteins and form tight junction-
like structures with the adjacent epithelial cells [40]. These
intestinal DC are thought to sample the luminal contents
and to bind and internalize pathogenic microorganisms
without disruption of the epithelial barrier. The formation
and extension of these DC processes requires the expression
of the chemokine, fractalkine (CX3CL1), by the intestinal
epithelial cells, and the expression of the fractalkine receptor,
CX3CR1, by the DC [34]. The ducts and acini of human
salivary glands express fractalkine, although variably [23].
It remains to be determined if the recruitment of DC to the
ducts and acini of the salivary glands and their migration
into the epithelium occurs in response to fractalkine
expression. Although we did not observe DC processes
exposed at the luminal surface of the salivary gland ducts,
HLA-DR-reactive DC processes frequently were seen
extending toward the lumen, in some cases within 2–3 μm
of the surface.
The location of salivary DC within the glandular
epithelium would appear to be optimal for the major
functions of these cells, immune surveillance, T- and B-cell
activation to initiate an immune response, and the develop-
ment and maintenance of tolerance to self antigens.
Ascending infections of the salivary gland ducts could
expose DC within the epithelium of the main duct and
probably large interlobular ducts to microorganisms and
their products. The organized, duct-associated lymphoid
tissue (DALT) around the oral openings of the excretory
ducts [26, 32], as well as a more diffuse distribution of
immune cells along the parotid main duct [21], are impor-
tant in the local response to an infection. Whether or not
ascending infectious material would reach the smaller
interlobular excretory ducts and intralobular striated ducts,
which are well-endowed with DC, is unknown. In these
locations and in the acini, maintenance of tolerance to the
numerous cellular and secreted molecules produced by the
acinar and ductal epithelial cells may be an important
function of the DC. Uptake of self-antigens, e.g., from
apoptotic cells or from leakage of secretory products
through tight junctions to the intercellular spaces, would
lead to presentation of the antigens to naïve circulating T-
cells, and result in the development of anergy or deletion
of autoreactive cells, or the induction of suppressor regu-
latory T-cells [45, 57]. In the development of autoimmune
diseases, such as SS, the local cytokine environment may
lead to dysregulation of salivary gland DC, with subsequent
maturation and stimulation of autoreactive T-cells [57].
In summary, DC are common constituents of normal
human salivary glands.They are present in the epithelium
of the acini and ducts, and in the interstitial tissues of the
major salivary glands. The DC are characterized by their
shape, nuclear and cytoplasmic structure, lack of intercellular
junctions with adjacent epithelial cells, and expression of
molecules characteristic of DC, such as MHC II and CD11c.
The location of DC within acinar and ductal epithelium
suggests a role in responding to foreign antigens and/or
maintaining immunological tolerance to salivary proteins.
Further studies are necessary to completely characterize the
various DC subsets present in the salivary glands, and their
function in normal and pathological conditions.
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